Invasive fungal disease (IFD) is a common cause of morbidity and mortality in patients with
hematologic malignancies, especially among those undergoing allogeneic hematopoietic …

Abstract The China Assessment of Antifungal Therapy in Hematological Disease study, the
first large-scale observational study of invasive fungal disease (IFD) in China, enrolled 1401 …

Invasive fungal infections (IFIs) continue to cause considerable morbidity and mortality in
haematopoietic stem cell transplant recipients. The epidemiology of IFI has changed since …

In recent years, prospective studies have been conducted to assess the role of prophylaxis
and treatment of invasive fungal diseases (IFD) in allogeneic hematopoietic stem cell …

Background Allogeneic hematopoietic stem cell transplant (HSCT) recipients experience an
increased risk for invasive fungal diseases (IFDs). Methods This retrospective cohort study at …

Background. With use of data from the Prospective Antifungal Therapy (PATH) Alliance
registry, we performed this multicenter, prospective, observational study to assess the …

Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic
stem cell transplantation (allo-HSCT) may be useful to identify subpopulations who might …

Contemporary, comprehensive data on epidemiology and outcomes of invasive fungal
disease (IFD) including breakthrough IFD among allogeneic hematopoietic stem cell …

The practice of hematopoietic stem cell transplantation (HSCT) has undergone many
changes that affect the likelihood that a given patient would develop an invasive fungal …

Patients with hematological cancer have a high risk of invasive fungal diseases (IFDs).
These infections are mostly life threatening and an early diagnosis and initiation of …